astrointestinal disease is one of the serious complications that can follow after cardiac surgery, and can lead to high rates of morbidity and mortality. 1,2 Particularly, postoperative bleeding from the upper gastrointestinal (GI) system is quite lethal, because coagulopathy can develop as patients undergo anti-coagulant therapy. Therefore, prophylactic treatment for upper GI diseases after open heart surgery appears very necessary. Several investigators have reported the incidence and risk factors for stress ulceration and upper GI bleeding in patients after cardiac surgery. 3,4 However, there are no randomized controlled trials of the incidence of these lesions and the effects of prophylactic treatment in adult patients undergoing open heart surgery. We designed a prospective randomized trial to test the efficacy of different antisecretory agents, such as histamine-2 (H2)-receptor antagonists and a proton pump inhibitor (PPI) to prevent upper GI complications after open heart surgery.
Methods
The Ethics committee of Nihon University School of Medicine approved the current trial. Between January 2001 and December 2003, 210 patients, 157 males and 53 females (average age 64.5±9.3 years, range: 28-80), without a history of upper GI diseases and who were to undergo open heart surgery were enrolled in this trial. All patients gave written informed consent. One hundred and forty patients underwent conventional coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB), 42 had valve replacement, and 28 had aortic surgery. In CABG, gastroepiploic artery was not used as a conduit. We divided them into 3 groups: group I had 70 patients who had mucosal protection (teprenone 150 mg/day) as a control group, group II consisted of 70 patients who had H2-receptor antagonist (ranitidine hydrochloride 300 mg/day), and group III included 70 patients who had a proton pump inhibitor (sodium rabeprazole 10 mg/day). The patient's characteristics are shown in Table 1 . All patients ingested the agents in a tablet form from the first postoperative day. Systemic heparinization (10,000 U/day) was delayed until the second postoperative day. Patients undergoing CABG or aortic surgery had aspirin (81 mg/day) and those with valve replacement were administered Warfarin (2-3 mg/day) from the first postoperative day. Even though there was no complaints in relation to the upper GI system, gastric fiberscopy (GFS) was used in all patients postoperatively during days 5 to 7. We compared the 3 groups in terms of 
Results
Prevalence of hypertension, diabetes, renal insufficiency (serum creatinine level of more than 2.0 mg/dl), and smoking history were similar ( Table 1) . The rates of operative characteristics such as CABG, valve replacement, and aortic surgery were also similar ( Table 1 ). There were also no differences regarding CPB duration, postoperative maximum creatine kinase (CK)-MB levels (Table 1) . Postoperative duration of hospital stay was significantly shorter in group III than in the other groups (Table 1) . Gastric pain was indicated in 8 patients in group I (11.4%), and 5 patients in group II (7.1%), and just 1 patient in group III (1.4%) (Table 2); the incidence of postoperative gastric pain being significantly lower in group III than the other 2 groups (p=0.028, Table 2 ). GFS showed that approximately 40% of all patients in all groups had hiatus hernia (Table 2) . However, there was no difference in the incidence of esophagitis between the groups (Table 2) . Neither were there any differences in terms of the incidence of superficial gastritis (I: 31.4%, II: 40%, III: 35.7%) or erosive gastritis (I: 17.1%, II: 22.9%, III: 18.6%). The incidence of hemorrhagic gastritis was significantly higher in groups I (22.9%) and II (15.7%) than in group III (2.9%) (p=0.0003, Table 2 ). The incidence of active ulcers was also significantly higher in groups I (28.6%) and II (21.4%) than in group III (4.3%) (p=0.0001, Table 2 ). There was hematemesis complications in 4 patients during postoperative days 4 and 6 in each of groups I and II (5.9%) ( Table 2) . These patients required a blood transfusion and all had emergency GFS, and 2 patients in each group had artery clipping. One patient from each of group I and II, who received artery clipping, and who had preoperative renal insufficiency, died of coagulopathy. Otherwise, those with active ulcers were completely healed by PPI administered for 2 weeks, and confirmed by GFS. In contrast, in group III, no patients developed upper GI bleeding (p=0.006) ( Table 2 ). Postoperative duration of hospital stay for the patients complicated by gastric bleeding was 34.1±6.6 days. This was significantly longer than the postoperative duration of hospital stay for the patients without gastric bleeding (13.3±2.4 days, p<0.0001). Early stage gastric cancers were coincidently detected in 4 patients ( Table 2) ; all have been well after gastrectomy.
Discussion
Since Berkowitz et al 5 first reported acute peptic ulcers after cardiac surgery in 1957, there have been several clinical studies concerning upper GI complications in patients after cardiac surgery. [1] [2] [3] [4] However, the majority of those reports were retrospective studies. Behrens et al performed a randomized trial for prophylaxis for upper GI lesions in high-risk pediatric heart surgery patients. 6 However, a randomized, controlled trial concerning pharmacologic stress ulcer prophylaxis has not been performed in an adult cardiac surgery population. Therefore, it has not been ascertained whether patients undergoing cardiac surgery should be treated prophylactically to prevent upper GI complications. Since H2-recepter antagonists have been introduced, upper GI disease has dramatically decreased throughout the world. 7 However, in the patients undergoing cardiac surgery, there are serious psychological and physiological stresses such as CPB and longer duration of anesthesia, which can be the cause of upper GI complications. 4 In a meta-analysis, it was shown that H2-receptor antagonists were effective in preventing clinically important GI bleeding in general intensive care patients. 8 In adult cardiac surgeries, however, Halm et al reported that even though prophylaxis ranitidine was used, the incidence of upper GI bleeding was still 0.9%. 9 van der Voort and Zandstra also reported that the incidence of stress ulcers was not reduced by prophylactic treatment with H2-receptor antagonist. 10 Since 1991 PPI has been presented in Japan as a more effective treatment for upper GI lesions. 11 However, no trial has been developed to test the efficacy of PPI to prevent upper GI complications after cardiac surgery.
Previous studies have reported that the incidence of upper GI complications after cardiac surgery, which are associated with a high mortality rate, was approximately 1 to 22%. 3, 4, 10, 12 Taylor et al reported that the overall mortality for the patients complicated by upper GI bleeding after cardiac surgery was 23.6%. 4 Several investigators have reported that multivariate analysis identified renal insufficiency, prolonged CPB, prolonged intubation, sepsis, or a cerebrovascular incident as significant predictive variables of GI complications after cardiac surgery. 3, 4, 13 In the present study, preoperative patient characteristics were similar among the groups, and there was no difference in terms of operative characteristics, CPB duration, and postoperative maximum. CK-MB levels, indicating surgical stress, was similar among all patients. As a result of the onset of ulceration and most upper GI complications occur within 5 and 10 days of cardiac surgery, 3, 14 we performed GFS in all patients postoperatively during days 5 to 7. We believe that the effects of prophylactic treatment can be gauged only by endoscopic findings; this is because diagnosis is often delayed because of the absence of early specific clinical signs. In the present study, although there were no significant difference regarding superficial gastritis and erosive gastritis; more critical lesions, such as hemorrhagic gastritis and active ulcers could be more effectively protected by PPI than by H2-receptor antagonists. Furthermore, 8 of the 210 patients (3.8%) were complicated by upper GI bleeding; none of these had taken prophylactic PPI. Indeed 2 of them (25%) died of coagulopathy; both having had renal insufficiency preoperatively. Therefore, patients who easily develop acute renal failure from hemorrhagic shock, might be the cause of coagulopathy and multiple organ failure. Preoperative renal insufficiency is one of the predictors for upper GI bleeding after cardiac surgery; 3,4,13 thus particular care, using prophylactic PPI, is needed for such high-risk patients. In fact, the active ulcers of the other 6 patients were completely healed by 2 weeks of treatment with PPI. Proton pump inhibitor noncompetitively inhibits H + , K + -adenosine triphosphatase, which participates in the final step in acid secretion from gastric parietal cells, and is considered the most effective of the currently available antisecretory agents. 15 In particular, rabeprazole has been shown to be effective and safe in the treatment of both gastric and duodenal ulcers, even in patients who have failed therapy with either H2-receptor antagonists or other PPI. 16 The H2-receptor antagonist, from the antagonism among histamine receptors, keeps the gastric pH level at more than 3, particularly during night-time. However, during the daytime the gastric pH level tends to come back to less than 3. 17 In adult cardiac surgery, patients usually have critical physiological and psychological stress; 4 in particular during the daytime due to bed rest, offensive sounds from the electrocardiogram monitor, and uncontrollable surgical site pain. During the daytime, therefore, acetylcholine receptor may be more associated with gastric acid secretion than histamine receptor. We believe it is important to maintain the gastric pH level at more than 3 during both night-time and daytime. The PPI, which can strictly maintain the gastric pH level at more than 3 for 24 h, 17 is considered to be an attractive prophylaxis for upper GI complications after open heart surgery.
Finally, we should mention the cost benefit of such prophylactic medications. Postoperative duration of hospital stay was approximately 2 weeks for the patients without critical gastric bleeding. If the patients had antisecretory agents for 2 weeks after cardiac surgery, it would require ¥650 for teprenone (150 mg/day), ¥1,640 for ranitidine (300 mg/day), and ¥3,245 for rabeprazole (10 mg/day), respectively. Obviously, the cost of PPI is twice as much as that of the H2-receptor antagonist and 5 times as much as that of teprenone. However, if the patient had gastric bleeding once after cardiac surgery, this would require blood transfusion, intensive care, and longer duration of hospital stay, all adding to increased costs. In the present study, 8 patients had gastric bleeding and the total cost for antisecretory agents totaled approximately ¥7,500. Furthermore, 4 of these 8 patients died of coagulopathy. The safety of the patient is more important at any cost.
Conclusion
Postoperative early prophylactic medication by a proton pump inhibitor has been shown to be the most effective treatment, and indeed could even be considered mandatory, to prevent upper GI complications after open heart surgery.
